Gaudium IVF And Women Health IPO
Open MainLineCurrent GMP
₹-4 (-5.06%)
Price Band
₹ 75 – 79
Lot Size
189
Issue Size
₹165 Cr
Minimum Investment
₹14931 (189 Shares)
Listing Date
27 February 2026
Subscription
7.27x
About the Company
Gaudium IVF & Women Health Limited is a pan-India fertility and women’s healthcare provider, incorporated in March 2015. The company delivers Assisted Reproductive Technology (ART) services through a scalable hub-and-spoke model, enabling operational efficiency and wider patient reach across India.
Gaudium IVF operates over 30 locations, including seven company-owned hub centres and 28 spoke centres developed through strategic alliances with leading infertility specialists. Its hubs are situated in key urban markets—two in Delhi (Janakpuri and Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bengaluru—ensuring strong geographic coverage and accessibility. The company also serves international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company offers a comprehensive range of fertility treatments, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Frozen Embryo Transfer (FET), ovulation induction, fertility preservation through cryopreservation, and advanced genetic screening such as Preimplantation Genetic Testing (PGT). In addition to reproductive medicine, Gaudium provides integrated gynecological and obstetric services, including treatment for PCOD/PCOS, endometriosis management, high-risk pregnancy care, male infertility treatments, and minimally invasive laparoscopic and hysteroscopic procedures.
A key differentiator of the company is its holistic and patient-centric approach. Beyond clinical treatment, Gaudium IVF integrates fertility wellness programs that include nutritional counseling and psychological support to enhance patient outcomes. As of March 31, 2025, the company had a workforce of 124 employees, including seven consultancy doctors.
Competitive Strengths
- Strong patient-centric care model
- Experienced and specialized medical team
- Advanced laboratory infrastructure, including next-generation INTEGRA Ti labs for ICSI
- Highly technical ultrasound-guided (USG) services
- Strategically located hubs in prime urban centres
- Asset-light and scalable hub-and-spoke operating model
Overall, Gaudium IVF & Women Health Limited combines clinical expertise, advanced reproductive technologies, and a scalable business structure to strengthen its position in India’s growing fertility care market.
Promoters
- Dr. Manika Khanna
- Dr. Peeyush Khanna
- Vishad Khanna
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
71.30%
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure towards establishment of New IVF Centers of our Company . : 50.00Cr
- Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company. : 20.00Cr
- General Corporate Purposes
Address / Contact Info
Gaudium IVF & Women Health Limited
B1/51,Janak Puri,B-1,
New Delhi, New Delhi, 110058
Email:compliance@gaudiumivfcentre.com
Telephone: 011- 4885 8585.
Website:http://www.gaudiumivfcentre.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Friday, 20 February 2026
IPO Close Date
Tuesday, 24 February 2026
Basis of Allotment
Wednesday, 25 February 2026
Initiation of Refunds
Wednesday, 25 February 2026
Credit of Shares to Demat
Thursday, 26 February 2026
Listing Date
Friday, 27 February 2026 — NSE & BSE
Important Dates
Open Date
20 February 2026
Close Date
24 February 2026
Basis Of Allotment
25 February 2026
Listing Date
27 February 2026
Financial Performance (₹ in Crores)
| Particular | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Revenue | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| Net Worth | 58.85 | 46.3 | 26.99 | 22.73 |
| Reserve & Surplus | 28.16 | 15.6 | 26 | 21.74 |
| Total Borrowings | 22.51 | 18.93 | 15.73 | 9.78 |
EPS Pre
3.12%
EPS Post
3.44%
P/E Pre
25.36
P/E (Post Issue)
22.99x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 21.25 | 41.31 | 38.23 | 59.51 |
| ROCE % | 21.03 | 39.7 | 38.74 | 54.4 |
| Debt / Equity | 0.38 | 0.41 | 0.58 | 0.43 |
| RoNW % | 21.34 | 41.71 | 39.3 | 59.11 |
| PbW | 0 | 0 | 0 | 0 |
| Pat Margin % | 25.14 | 26.96 | 21.43 | 30.56 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 4177240 | 28.57 | 0 |
| Non-Institutional | 3132930 | 21.43 | 0 |
| BNII | 2088620 | 14.29 | 0 |
| SNII | 1044310 | 7.14 | 0 |
| Retail Investors | 7310170 | 50 | 0 |
| Total | 14620340 | 100 | 0 |
Subscription Status ( Tue, 24 Feb 26 01:36 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 4177240 | 6785478 | 1.62x |
| Non-Institutional | 3132930 | 44022069 | 14.05x |
| BNII | 2088620 | 26555634 | 12.71x |
| SNII | 1044310 | 17466435 | 16.73x |
| Retail Investors | 7310170 | 55542942 | 7.6x |
| Total | 14620340 | 106350489 | 7.27x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Gaudium IVF and Women Health Ltd | 5 | 0.00 | 3.12 | 3.12 | 41.71 | 7.54 |
| Progyny Inc. | 0.0001 | 41.56 | 50.52 | 50.52 | 12.90 | 394.20 |
| Inspire IVF Public Company Ltd | 0.05 | 11.43 | 0.17 | 0.17 | 3.97 | 4.34 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 189 | 14,931.00 |
| Retail (Max) | 13 | 2,457 | 194,103.00 |
| S-HNI (Min) | 14 | 2,646 | 209,034.00 |
| S-HNI (Max) | 66 | 12,474 | 985,446.00 |
| B-HNI (Min) | 67 | 12,663 | 1,000,377.00 |
Registrar
Bigshare Services Pvt Ltd
91-22-6263 8200
investor@bigshareonline.com
https://www.bigshareonline.com
Book Running Lead Managers
- Sarthi Capital Advisors Private Limited
RHP Document
DRHP Document
Anchor Investors
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Gaudium IVF And Women Health IPO is a Book-building IPO worth ₹165 crores. The price band is ₹75 to 79 per share. The IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026. It will be listed on BSE and NSE. Bigshare Services Pvt Ltd is the registrar.
The Gaudium IVF And Women Health IPO opens on Fri, Feb 20, 2026 and closes on Tue, Feb 24, 2026
Gaudium IVF And Women Health IPO Price Band is ₹75 to 79.
Gaudium IVF And Women Health IPO lot size is 189, and the minimum amount required for application is ₹14931.
The minimum investment for Gaudium IVF And Women Health IPO is approximately ₹14931 based on the upper price band.
To apply for the Gaudium IVF And Women Health IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Feb 24, 2026. After submission, funds are blocked until the basis of allotment of Gaudium IVF And Women Health IPO is finalised.
Gaudium IVF And Women Health IPO issue size is ₹165 crores.
Gaudium IVF And Women Health IPO allotment date is Sat, Jun 27, 2026.
The registrar for Gaudium IVF And Women Health IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Gaudium IVF And Women Health IPO through their official website or helpline.
The Gaudium IVF And Women Health IPO GMP (Grey Market Premium) is ₹0 as of Fri, Feb 27, 2026. Based on the upper price band of ₹79 per share, the estimated Gaudium IVF And Women Health IPO listing price is ₹79, indicating a potential listing gain of approximately 31% over the issue price.